Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For TSLA
Valuation Bad
0%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.59 1.72 1.73
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 70.87 -0.93 -3.21
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.62 20.21 19.69
Cash -6.57 8.55 9.15
Capex -20.18 -0.87 -0.73
Free Cash Flow 22.69 -0.80 0.65
Revenue -15.49 6.69 7.91
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.60 0.17 0.18
Operating Margin -32.97 0.05 0.08
ROA -86.10 0.01 0.07
ROE -86.15 0.02 0.13
ROIC -88.90 0.01 0.11
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of TSLA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of TSLA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of TSLA is permitted for members.